Controlling Blood Pressure in 50% of All Hypertensive Patients: An Achievable Goal in the Healthy People 2010 Report?

Journal of Investigative Medicine

Volumn 51, Issue 6, 2003, Pages 373-385

  Egan, Brent M ^a   Basile, Jan N ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Healthy People 2010; High blood pressure; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADVERSE DRUG REACTION; AWARENESS; BLOOD PRESSURE REGULATION; COOPERATION; DEMOGRAPHY; ECONOMIC ASPECT; ETHNIC DIFFERENCE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; HYPERTENSION; MEDICAL LITERATURE; OBESITY; PATIENT COMPLIANCE; REVIEW; UNITED STATES;

EID: 0345167847     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-51-06-34     Document Type: Review

References (100)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
2. Healthy People 2010: US Government Printing Office No. 017-001-00547-9. Available at: http://www.healthypeople.gov/publications (accessed July 2003).
3. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-8.
4. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-81.
5. Tuomilehto J, Rastenyte D, Birkenhager WH, et al for the Systolic Hypertension in Europe Trial Investigators. Effects of calcium channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999;340:677-84.
6. Five-year findings of the Hypertension Detection and Follow-Up Program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982;247:633-8.
7. United Kingdom Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-13.
8. National Center for Health Statistics. Blood pressure of adults by age and sex, United States, 1960-1962. Vital Health Stat 1964;11:4.
9. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypetension in the adult U.S. population: data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9.
10. Jones DW, Hall JE. The National High Blood Pressure Education Program: thirty years and counting. Hypertension 2002;39:941-2.
11. Julius S, Kjeldsen SE, Brunner H, et al. VALUE Trial: long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. Am J Hypertens 2003;16:544-8.
12. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens 2002;4:393-405.
13. Black HR, Elliott WJ, Grandits G, et al. Principal results of the Controlled Onsent Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003;289:2073-82.
14. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001;37:869-74.
15. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge and attitudes of older Americans about high blood pressure: implications for healthcare policy, education and research. Arch Intern Med 2003;163:681-7.
16. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med 2000;160:2281-6.
17. Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension? JAMA 1988;259:225-8.
18. Mejia A, Egan B, Schork N, Zweifler A. Importance of blood pressure measurement artefacts and lack of target organ involvement in the assessment of patients with treatment resistant hypertension. Ann Intern Med 1990;112:270-7.
19. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001;14:1263-9.
20. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 1998;98:1892-7.
21. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282:539-46.
22. Clement DL, DeBuyzere ML, DeBacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-15.
23. Thijs L, Staessen JA, Celis H, et al. Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med 1998;158:481-8.
24. National Heart, Lung, and Blood Institute, National Institutes of Health. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. November 1997. NIH Publication No.: 98-4080. Bestheda (MD): National Institutes of Health; 1997.
25. Materson BJ, Reda DJ, Preston RA, et al. Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug. Arch Intern Med 1995;155:1757-62.
26. Weber MA, Drayer JI. Single-agent and combination therapy of essential hypertension. Am Heart J 1984;108:311-6.
27. Wing LMH, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92.
28. Laragh JH. Laragh's lessons in renin system pathophysiology for treating hypertension and its fatal cardiovascular consequences. New York: Elsevier Science Inc.; 2002.
29. Blumenfeld JD, Laragh JH. Renin system analysis: a rational method for the diagnosis and treatment of the individual patient with hypertension. Am J Hypertens 1998;11:894-6.
30. Setaro JF, Black HR. Refractory hypertension: review article. N Engl J Med 1992;327:543-7.
31. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345:479-86.
32. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Study. Circulation 2001;103:1188-90.
33. Levy D, Kannel WB. Cardiovascular risk: new insights from Framingham. Am Heart J 1988;116(1 Pt 2):266-72.
34. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: mortality by race, sex and age. JAMA 1979;242:2572-7.
35. Weinick RM, Zuvekas SH, Cohen JW. Racial and ethnic differences in access to and use of health care services. Med Care Res Rev 2000;57 Suppl 1:36-54.
36. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999;282:1458-65.
37. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;27:1957-63.
38. Townsend RR, Shulkin DJ, Bernard D. Improved outpatient hypertension control with disease management guidelines. Am J Hypertens 1999;12:88.
39. Yegian JM, Pockell DG, Smith MD, Murray EK. The nonpoor uninsured in California, 1998. Health Aff (Millwood) 2000;19:171-7.
40. Solberg LI, Brekke ML, Kottke TE. Are physicians less likely to recommend preventive services to low-SES patients? Prev Med 1997;26:350-7.
41. Weir MR, Maibach EW, Bakris GL, et al. Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med 2000;160:481-90.
42. Richardson MA, Post-White J, Singletary SE, Justice B. Recruitment for complementary/alternative medicine trials: who participates after breast cancer? Ann Behav Med 1998;20:190-8.
43. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998;21:1391-6.
44. Langfield S. Hypertension: deficient care in the medically served. Ann Intern Med 1973;78:19-23.
45. Haynes RB, Taylor W, Sackett DL, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:656-64.
46. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care 1981;19:1061-4.
47. Meland E, Maeland JG, Laerum E. The importance of self-efficacy in cardiovascular risk factor change. Scand J Public Health 1999;27:11-7.
48. Alexander M, Tekawa I, Hunkeler E, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med 1999;159:2673-7.
49. Ferguson RP, Wetle T, Dubitzky D, Winsemius D. Relative importance to elderly patients of effectiveness, adverse effects, convenience and cost of antihypertensive medications. A pilot study. Drugs Aging 1994;4:56-62.
50. Lackland D, Egan B, Cheek D, Dunbar J. Racial differences in the use of office-based medical services for blood pressure assessment. Am J Hypertens 1993;6:88A.
51. Wheeler FC, Lackland DT, Mace ML, et al. Evaluating South Carolina's community cardiovascular disease prevention project. Public Health Rep 1991;106:536-43.
52. Kirscht JP, Rosenstock IM. Patient adherence to antihypertensive medical regimens. J Community Health 1977;3:115-24.
53. Skelly AH, Marshall JR, Haughey BP, et al. Self-efficacy and confidence in outcomes as determinants of self-care practices in inner-city, African-American women with noninsulin-dependent diabetes. Diabetes Educator 1995;21:38-46.
54. Jackson AL. Operation Sunday School-educating caring hearts to be healthy hearts. Public Health Rep 1990;105:85-8.
55. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med 1997;23:7-14.
56. Shea S, Misra D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 1992;82:1607-12.
57. David SK, Winkleby MA, Farquhar JW. Increasing disparity in knowledge of cardiovascular disease risk factors and risk-reduction strategies by socioeconomic status: implications for policymakers. Am J Prev Med 1995;11:318-23.
58. Gates G, McDonald M. Comparison of dietary risk factors for cardiovascular disease in African-American and white women. J Am Diet Assoc 1997;97:1394-400.
59. Kayrooz K, Moy TF, Yanek JL, Becker DM. Dietary fat patterns in urban African-American women. J Community Health 1998;23:453-69.
60. Karanza NM, McCullough ML, Kumanyika SK, et al. Pre-enrollment diets of Dietary Approaches to Stop Hypertension trial participants. J Am Diet Assoc 1998;99(8 Suppl):S28-34.
61. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins and incidence of stroke. Arch Intern Med 1996;154:637-42.
62. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999;282:1233-9.
63. Appel JL, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.
64. Svetkey LP, Moore TJ, Simons-Morton DG, et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens 2001;19:1949-56.
65. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med 2000;160:2101-7.
66. Lang T, Degoulet P, Aime F, et al. Relationship between alcohol consumption and hypertension prevalence and control in a French population. J Chron Dis 1987;40:713-20.
67. Andrus MR, Roth MT. Health literacy: a review. Pharmacotherapy 2002;22:282-302.
68. Weiss BD. Health literacy: an important issue for communicating health information to our patients. Chin Med J (Engl) 2001;64:603-8.
69. Parikh NS, Parker RM, Nurss JR, et al. Shame and health literacy: the unspoken connection. Pat Educ Couns 1996;27:33-9.
70. van der Pol M, Cairns J. Estimating time preferences for health using discrete choice experiments. Soc Sci Med 2001;52:1459-70.
71. Enemark U, Lyttkens CH, Troeng T, et al. Implicit discount rates of vascular surgeons in the management of abdominal aortic aneurysms. Med Decis Making 1998;18:168-77.
72. Ganiats TG, Carson RT, Hamm RM, et al. Population-based time preferences for future health outcomes. Med Decis Making 2000;20:263-70.
73. Chapman GB. Temporal discounting and utility for health and money. J Exp Psychol Learn Mem Cogn 1996;22:771-91.
74. West RR. Discounting the future: influence of the economic model. J Epidemiol Community Health 1996;50:239-44.
75. Parsonage M, Neuburger H. Discounting and health benefits. Health Econ 1992;1:71-6.
76. Sanson-Fisher RW, Campbell EM, Redman S, Hennrikus DJ. Patient-provider interactions and patient outcomes. Diabetes Educator 1989;15:134-8.
77. Shank JC, Powell T, Llewelyn J. A five-year demonstration project associated with improvement in physician health maintenance behavior. Fam Med 1989;21:273-8.
78. Sciamanna CN, Tate DF, Lang W, Wing RR. Who reports receiving advice to lose weight? Results from a multistate survey. Arch Intern Med 2000;160:2334-9.
79. Ruggiero L, Rossi JS, Prochaska JO, et al. Smoking and diabetes: readiness for change and provider advice. Addict Behav 1999;24:573-8.
80. Schoenberger JA. Topics in hypertension: patient compliance in antihypertensive therapy. New York: American Society of Hypertension; 1997.
81. Dunbar JM, Stunkard AJ. Adherence to diet and drug regimen. In: Levy R, Rifkin B, Dennis B, Ernst N, editors. Nutrition, lipids and coronary heart disease. New York: Raven Press; 1979. p. 391-423.
82. Beesesen DH. Applying stages of change theory to office-based counseling. In: Beesesen DH, Kushner R, editors. Evaluation and management of obesity. Philadelphia: Hanley & Belfus; 2002. p. 33-9.
83. Diehl NS, Evenson KR. Exercise: getting your patient going in 3 minutes or less. In: Egan BM, Basile JN, Lackland DT, editors. Hot topics in hypertension: a TRIP with the experts. Philadelphia: Hanley & Belfus; 2003. [In press]
84. Ruzicka M, Leenen FHH. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension. Drugs 2001;61:944-54.
85. Ashida T, Sugiyama T, Okuno S, et al. Relationship between home blood pressure measurement and medication compliance and name recognition of antihypertensive drugs. Hypertens Res Clin Exp 2000;23:21-4.
86. Johnson AL, Taylor W, Sackett DL, et al. Self-recording of blood pressure in the management of hypertension. Can Med Assoc J 1978;119:1034-9.
87. Mehos BM, Saseen JJ, MacLaughlin EF. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20:1384-9.
88. Rogers MA, Small D, Buchan DA, et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med 2001;134:1024-32.
89. Frishman WH. Effects of nonsteroidal anti-inflammatory drug therapy on blood pressure and peripheral edema. Am J Cardiol 2002;89(6A):18D-25D.
90. Blackshear JL, Schwartz GL. Step care therapy for hypertension in diabetic patients. Mayo Clin Proc 2001;76:1266-74.
91. Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African-American hypertensives. Soc Sci Med 1996;43:903-17.
92. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-79.
93. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. JAMA 2002;288:2880-3.
94. Inui TS, Yourtee EL, Williamson JW. Improved outcomes in hypertension after physician tutorials: a controlled trial. Ann Intern Med 1976;84:646-51.
95. Keller VF, Carroll JG. A new model for physician-patient communication. Pat Educ Couns 1994;23:131-40.
96. Ryan D, Carr A. A study of the differential effects of Tomm's questioning styles on therapeutic alliance. Fam Process 2001;40:67-77.
97. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care 1988;26:657-75.
98. Isaksson H, Ostergren J. Prognosis in therapy-resistant hypertension. J Intern Med 1994;236:643-9.
99. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for regression dilution bias. Lancet 1990;335:765-74.
100. Egan BM, Lackland DT, Basile JN. American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community. Am J Hypertens 2002;15:372-9.